----------- ----------- ----------- -----------
REVENUES
$ 20,024 $ 23,106 Product sales $ 76,072 $ 83,545
463 1,290 Royalty and licensing 2,788 5,422
-------------------------------------------------------------------------
20,487 24,396 78,860 88,967
-------------------------------------------------------------------------
EXPENSES
13,115 12,660 Cost of goods sold, 49,618 47,083
excluding depreciation
and amortization (Note 3)
6,680 5,672 Selling, general and 18,807 19,425
administration
173 392 Research and development 2,446 2,372
1,690 1,383 Depreciation and 5,841 5,135
amortization
-------------------------------------------------------------------------
21,658 20,107 76,712 74,015
-------------------------------------------------------------------------
(1,171) 4,289 Operating income (loss) 2,148 14,952
265 228 Financing income, net 870 347
(71) 522 Foreign exchange (1,716) 282
(loss) gain
-------------------------------------------------------------------------
(977) 5,039 Income (loss) before 1,302 15,581
income taxes
426 (1,352) Income taxes recovery 356 (4,034)
(expense)
---------------------------------
'/>"/>
| SOURCE DRAXIS Health Inc. Copyright©2008 PR Newswire. All rights reserved |